CD8A and COVID-19: It was determined (Figure 1B) that there were no significant differences in the relative count of CD8+ T lymphocytes in patients with moderate (23.07% (18.66; 27.20)), severe (20.75% (14.32; 27.78)) COVID-19 patients, and healthy donors (23.42% (19.55; 29.89)).